Dr. V Mohan writes about the old oral anti-diabetic drugs like sulphonylureas and biguanides, their advantages and disadvantages in practice, and the recent drugs that he considers to be as good anti-diabetic therapies for Indian patients.
Dr. V Mohan in his exclusive series on Diabetes, discusses steps for management of hypoglycemia (moderate to severe) in DM patients, factors that can contribute to risk, and dose adjustments for low blood sugar reactions.
Longevity with Diabetes: Dr. V Mohan’s research on nonagenarian Asian Indian patients proves it i...
One of India’s leading diabetologists, Dr. V. Mohan recently authored a study that draws a comparison between clinical profiles of T2DM patients ≥90 years and those between 50-60 years. The study is possibly the only one that concludes that diabetes patients can go beyond the average age expectancy.
Dr. V Mohan in his exclusive series on Diabetes, writes on the disease and associated complications that may lead to kidney disease in patients, also focusing on stages of progression and preventive measures that doctors can advise.
This time in the exclusive Diabetes series, Dr. V Mohan discusses the key benefits of exercise in diabetes, the types of activities that can be suggested, and useful exercise tips that can be advised to diabetes patients.
Dr. V Mohan writes that while there is no 'one size fits all' approach to preventing and controlling DM, educating diabetic and pre-diabetic patients on food groups, GI, and nutritional value of sweeteners can help them make smart diet decisions.
Dr. V Mohan, as part of this exclusive 12-article series on Diabetes, answers questions posted by readers on the previous article- Treatment algorithm; factors to consider while prescribing medication.
In the second article of the exclusive diabetes series, Dr. V Mohan writes on managing hypertension, the most common co-morbid condition present along with diabetes- a major risk factor for both microvascular as well as macrovascular complications.
Dr. V Mohan emphasises that diabetes is not a single disorder but a syndrome consisting of several types of diabetes all of which have in common raised blood glucose levels. Here he provides a quick treatment algorithm and details on the necessary factors to consider before planning treatment.
Dr. V Mohan, an expert in diabetology answers questions on the Keto diet and if it should be considered as a useful and sustainable diet for obese patients with diabetes or pre-diabetes.
Dr. V Mohan, a celebrated diabetology expert. Here, he writes about one of his patients who at 98 years is a fitting testament to the fact that it is possible to live a healthy and fulfilling life despite having diabetes!
In part 2 of the World Heart Day series, Dr. V Mohan, an eminent Diabetologist, and one of the lead investigators on PURE study provides his commentary on a chief finding- correlation between dairy intake and CVD, and what this means for India.
WHO recently published guidelines on treating and managing diabetes in low resource settings. Here we bring to you a commentary from Padma Shri Dr. V Mohan, an eminent Indian Diabetologist, who shares his views and opinions on the new guidelines.
In the Sunday series, we bring to you an article from our archives' most read section, in which Dr. V Mohan provides his response to the recent American College of Physicians Guidelines on diabetes which has generated a fair deal of interest and controversy in the field of diabetes.
Dr. V. Mohan, Chairman and Chief of Diabetology at Dr. Mohan's Diabetes Specialities Centre and Director of Madras Diabetes Research Foundation, an ICMR Centre for Advanced Research on Diabetes provides valuable advice to young doctors just starting out in the medical profession.
Here is Dr V Mohan's opinion on the recent Scandinavian research which classifies adult-onset diabetes into 5 cluster groups rather than the traditional type 1 and type 2 diabetes, he emphasises the fact that there can be other forms of diabetes that extend beyond this spectrum.
Dr V Mohan, a noted diabetologist from India has been selected by the American Diabetes Association (ADA) Awards Committee as the 2018 recipient of the Harold Rifkin Distinguished International Service in the Cause of Diabetes Award.